ABVX Latest Headlines

Abivax Shareholders Green-Light All Proposals at 2026 Annual General Meeting: Focus Sharpens on Phase 3 Developments

Market Chameleon (Tue, 12-May 9:13 AM)

Abivax Locks in $45M Offering and Retires Royalty Certificates, Extending Cash Runway Into Q4 2027

Market Chameleon (Tue, 5-May 7:08 AM)

Abivax Highlights Comprehensive Obefazimod Data at Upcoming Digestive Disease Week Conference

Market Chameleon (Thu, 23-Apr 8:27 AM)

Abivax Releases Full Preparatory Documents for May 2026 Shareholder Meeting: What Should Investors Watch?

Market Chameleon (Tue, 21-Apr 7:14 AM)

Abivax Releases 2025 Financial Reports—Key Filings Set the Stage for Phase 3 Ulcerative Colitis Trials

Market Chameleon (Thu, 2-Apr 7:08 AM)

Obefazimod Shows Promising Anti-Fibrotic and Rapid Symptomatic Relief in IBD, Abivax Data Highlights

Market Chameleon (Mon, 23-Feb 7:08 AM)